These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 24402103)

  • 1. Reviewing the Brazilian protocol for treatment of secondary hyperparathyroidism.
    Romão JE
    J Bras Nefrol; 2013; 35(4):250-1. PubMed ID: 24402103
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical protocol and therapeutic guidelines for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease].
    Custódio MR; Canziani ME; Moysés RM; Barreto FC; Neves CL; de Oliveira RB; Karohl C; Sampaio Ede A; Gueiros JE; Jorgetti V; de Carvalho AB
    J Bras Nefrol; 2013; 35(4):308-22. PubMed ID: 24402111
    [No Abstract]   [Full Text] [Related]  

  • 3. Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.
    Kazama JJ
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S44-7. PubMed ID: 17976085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in interventional treatment--from the viewpoint of percutaneous ethanol injection therapy.
    Kitaoka M
    Ther Apher Dial; 2008 Oct; 12 Suppl 1():S16-20. PubMed ID: 19032521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].
    Orita H; Akizawa T
    Clin Calcium; 2004 May; 14(5):693-7. PubMed ID: 15577029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Present status and problems in vitamin D and sevelamer therapy (discussion)].
    Tahara H; Yumita S; Ishida M; Tsuruta Y; Cunningham J; Fukagawa M; Tominaga Y; Tokumoto M; Onoda N
    Clin Calcium; 2005 Sep; 15 Suppl 1():225-8. PubMed ID: 16279028
    [No Abstract]   [Full Text] [Related]  

  • 7. Challenges in the therapy of secondary hyperparathyroidism.
    Wood C; González EA; Martin KJ
    Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients.
    Guideline Working Group, Japanese Society for Dialysis Therapy
    Ther Apher Dial; 2008 Dec; 12(6):514-25. PubMed ID: 19140852
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention and treatment of secondary hyperparathyroidism in CKD].
    Gueiros JE; Hernandes FR; Karohl C; Jorgetti V;
    J Bras Nefrol; 2011; 33(2):197-204. PubMed ID: 21789441
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention and treatment of secondary hyperparathyroidism in CKD].
    Gueiros JE; Hernandes FR; Karohl C; Jorgetti V;
    J Bras Nefrol; 2011 Apr; 33 Suppl 1():7-14. PubMed ID: 21655856
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of secondary hyperparathyroidism in children].
    Broyer M; Levy-Bentolila D; Balsan S
    Acquis Med Recent; 1978; ():97-104. PubMed ID: 757746
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe secondary hyperparathyroidism: intravenous calcitriol treatment or parathyroidectomy?
    Goicoechea Diezhandino M; Pérez-Garcia R; López-Gómez JM; Jofre R; Valderrábano F
    Clin Nephrol; 1996 Jan; 45(1):69-70. PubMed ID: 8616964
    [No Abstract]   [Full Text] [Related]  

  • 13. Mineral and bone disorders outcomes study for Japanese chronic kidney disease stage 5D patients: rationale and study design.
    Fukuhara S; Akizawa T; Fukagawa M; Onishi Y; Yamaguchi T; Hasegawa T; Kurokawa K
    Ther Apher Dial; 2011 Apr; 15(2):169-75. PubMed ID: 21426510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of secondary hyperparathyroidism. Proceedings of an international symposium on secondary hyperparathyroidism held by the Japanese Society for Parathyroid Intervention. August 17, 2002. Tokyo, Japan.
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii1-98. PubMed ID: 12771289
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of secondary hyperparathyroidism].
    Stein G
    Dtsch Med Wochenschr; 1999 Feb; 124(5):133-4. PubMed ID: 10076555
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of secondary hyperparathyroidism].
    Pichlmaier H; Edel HH
    Munch Med Wochenschr; 1971 Jun; 113(23):884-7. PubMed ID: 4931694
    [No Abstract]   [Full Text] [Related]  

  • 17. Attainment of the Japanese Society for Dialysis Therapy guidelines for the management of secondary hyperparathyroidism in chronic hemodialysis patients in our clinic.
    Sato Y; Eriguchi R; Umakoshi J; Kato M
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S48-53. PubMed ID: 17976086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidism.
    Yousaf F; Charytan C
    Ren Fail; 2014 Feb; 36(1):131-8. PubMed ID: 24060145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new treatments of hyperparathyroidism secondary to renal insufficiency.
    Fournier A; Drüeke T; Morinière P; Zingraff J; Boudailliez B; Achard JM
    Adv Nephrol Necker Hosp; 1992; 21():237-306. PubMed ID: 1566648
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hyperparathyroidism].
    Fujita T
    Horumon To Rinsho; 1974 Jan; 22(1):34-5. PubMed ID: 4857403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.